Heart Disease News and Research

Latest Heart Disease News and Research

Russian-trained microbiologist recommends tips for consumers to achieve effective results from probiotics

With the European Union poised to regulate probiotics, and with probiotic supplement sales increasing dramatically in the United States, Americans need to know what they're buying, and how these products can affect their health.

20 Nov 2010

PaedRegCliNet promotes development of medications for children

Many of the medications used to treat children have been developed almost exclusively for adults and approved for them. This is why pediatricians have been demanding for decades that medications be tailored specifically to the needs of the child's body and adequately tested on children. A regulation from the European Commission called the Pediatric Regulation has set out to solve this problem. Clinical studies involving children should ultimately give way to medications tailored for this age group.

20 Nov 2010

Medtronic's implantable device delivers positive results for abdominal aortic aneurysms treatment

An implantable medical device used in the minimally invasive treatment of abdominal aortic aneurysms, the Endurant Stent Graft System from Medtronic, Inc., delivered strong results through one year of patient follow-up in the company's U.S. pivotal study, according to clinical data presented at VEITHsymposium.

20 Nov 2010

Harvard researcher to receive 2010 Naomi Berrie Award from Columbia University Medical Center

Columbia University Medical Center will present the 2010 Naomi Berrie Award to a Harvard researcher who has made important advances in understanding the molecular basis for links between obesity, diabetes and heart disease. A promising young investigator at Columbia will also be recognized for her novel investigations regarding the basis for disordered lipid metabolism in diabetes.

20 Nov 2010

Gore sponsors EVEResT Lunch Symposium

W. L. Gore & Associates is sponsoring the EVEResT (European Virtual Reality Endovascular Research Team) Lunch Symposium taking place on Friday, Nov. 19 from 12:00 to 1:00 p.m. at the VEITHsymposium in the Gramercy A room, second floor. The symposium will detail the evidence for simulation in medical training and in other fields. Companies will demonstrate how new simulation technologies are designed to enhance performance in endovascular procedures.

20 Nov 2010

Genetic differences impact winter vitamin D status

Vitamin D is somewhat of an unusual "vitamin," because it can be made in the body from sunlight and most foods do not contain vitamin D unless added by fortification. Synthesis of vitamin D in the body requires exposure to ultraviolet light and can be influenced by genetics, skin color, and sun exposure.

20 Nov 2010

People with heart disease, diabetes or cancer believe economic downturn hurts their health: Poll

A new poll from researchers at the Harvard School of Public Health and Knowledge Networks shows that many people with heart disease, diabetes or cancer believe the economic downturn is hurting their health and will have further negative impacts in the future. Many Americans with these illnesses face financial problems paying for medical bills in this economy.

20 Nov 2010

Eastern Virginia professor says average doctor may be toting new pocket-sized ultrasound machine

Since the Civil War, the stethoscope has been a standard tool of the trade for physicians. Soon, the average doctor may be toting another valuable diagnostic tool: a pocket-sized ultrasound machine.

20 Nov 2010

Psychiatric hospitalization rate decreases among adults with schizophrenia treated with INVEGA SUSTENNA: Study

Schizophrenia is a chronic and disabling brain disorder that affects 1 percent of the U.S. population and results in substantial medical and societal costs, in particular from use of health-care resources. It also can have devastating health-related and social effects on people with the disease, their families and caregivers.

20 Nov 2010

Scientists discover Notch pathway may play a role in alcohol's protective effects

Many studies support the assertion that moderate drinking is beneficial when it comes to cardiovascular health, and for the first time scientists have discovered that a well-known molecule, called Notch, may be behind alcohol's protective effects. Down the road, this finding could help scientists create a new treatment for heart disease that mimics the beneficial influence of modest alcohol consumption.

20 Nov 2010

Vascular Disease Foundation urges diabetic patients to be alert about P.A.D. signs

P.A.D. occurs when arteries in the legs become narrowed or clogged with fatty deposits, reducing blood flow to the legs. This can result in leg muscle pain when walking, disability, amputation, and poor quality of life. Blocked arteries found in people with P.A.D. can be a red flag that other arteries, including those in the heart and brain, may also be blocked - increasing the risk of a heart attack or stroke.

20 Nov 2010

Children with higher waist circumferences more likely to have heart-related disorders: Researchers

In a study of more than 4,500 children, researchers found those with higher waist circumferences had significantly higher pulse pressures, which is known to increase the risk of heart-related disorders, according to an abstract presented today at the American Society of Nephrology's Renal Week conference in Denver.

20 Nov 2010

Scientist suggests functional amino acids play a critical role in human health

Functional amino acids play a critical role in the development of both animals and humans, according to a Texas AgriLife Research scientist.

20 Nov 2010

Insertable cardiac monitors may help physicians diagnose, treat patient with syncope: PICTURE trial

Medtronic, Inc. today announced the publication of data showing that use of its Reveal family of Insertable Cardiac Monitors led to diagnosis and specific treatment for 78 percent (170 of 218) of patients who experienced a recurrent syncopal (fainting) event during the course of the study.

20 Nov 2010

High CRP and low protein albumin levels associated with increased risk of death after PEG-operations

The combination of high CRP and low levels of the protein albumin in the blood, is associated with an increased risk of death after a PEG-operation; implantation of a nutritional catheter into the stomach through the abdominal wall. This was shown in a new study from the Swedish medical university Karolinska Institutet, published in the scientific journal Gastrointestinal Endoscopy. Of the PEG patients in the study that showed both current indicators, 20 percent died within 30 days.

20 Nov 2010

Thorax Institute presents 18-year experience with SynCardia Artificial Heart at Acute Cardiac Care meeting

On Oct. 17, Dr. Jean Christian Roussel from the Thorax Institute at University Hospital of Nantes presented the center's 18-year experience with the SynCardia temporary Total Artificial Heart at the Acute Cardiac Care 2010 medical meeting in Copenhagen, Denmark.

20 Nov 2010

Pfizer's Phase 3 AXIS 1032 trial for metastatic renal cell carcinoma meets primary endpoint

Pfizer Inc. announced today that the Phase 3 AXIS 1032 trial (A4061032), studying the investigational compound axitinib in previously treated patients with metastatic renal cell carcinoma (mRCC), has met its primary endpoint, demonstrating that axitinib significantly extended progression-free survival when compared to sorafenib, in the study population.

20 Nov 2010

Xanodyne Pharmaceuticals decides to voluntarily remove propoxyphene from the U.S. market

Xanodyne Pharmaceuticals Inc. which makes Darvon and Darvocet, the brand version of the prescription pain medication propoxyphene, has agreed to withdraw the medication from the U.S. market at the request of the U.S. Food and Drug Administration. The FDA has also informed the generic manufacturers of propoxyphene-containing products of Xanodyne's decision and requested that they voluntarily remove their products as well.

20 Nov 2010

Boston Scientific signs definitive agreement to acquire Sadra Medical

Boston Scientific Corporation today announced the signing of a definitive merger agreement, under which Boston Scientific will acquire Sadra Medical, Inc., a development-stage company in Los Gatos, California. Sadra is developing the first fully repositionable device for percutaneous aortic valve replacement to treat patients with severe aortic stenosis.

20 Nov 2010

Acceleron presents ACE-041 interim results for advanced cancer at EORTC-NCI-AACR Symposium

Acceleron Pharma, Inc., a biopharmaceutical company developing novel protein therapeutics that regulate the growth and development of tissues and cells, including muscle, bone, red blood cells, and vasculature, today announced the presentation of interim results from the first-in-human clinical study of ACE-041 in patients with advanced cancer at the 22nd EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Berlin, Germany.

20 Nov 2010

Heart Disease News and Research

Latest Heart Disease News and Research

Russian-trained microbiologist recommends tips for consumers to achieve effective results from probiotics

PaedRegCliNet promotes development of medications for children

Medtronic's implantable device delivers positive results for abdominal aortic aneurysms treatment

Harvard researcher to receive 2010 Naomi Berrie Award from Columbia University Medical Center

Gore sponsors EVEResT Lunch Symposium

Genetic differences impact winter vitamin D status

People with heart disease, diabetes or cancer believe economic downturn hurts their health: Poll

Eastern Virginia professor says average doctor may be toting new pocket-sized ultrasound machine

Psychiatric hospitalization rate decreases among adults with schizophrenia treated with INVEGA SUSTENNA: Study

Scientists discover Notch pathway may play a role in alcohol's protective effects

Vascular Disease Foundation urges diabetic patients to be alert about P.A.D. signs

Children with higher waist circumferences more likely to have heart-related disorders: Researchers

Scientist suggests functional amino acids play a critical role in human health

Insertable cardiac monitors may help physicians diagnose, treat patient with syncope: PICTURE trial

High CRP and low protein albumin levels associated with increased risk of death after PEG-operations

Thorax Institute presents 18-year experience with SynCardia Artificial Heart at Acute Cardiac Care meeting

Pfizer's Phase 3 AXIS 1032 trial for metastatic renal cell carcinoma meets primary endpoint

Xanodyne Pharmaceuticals decides to voluntarily remove propoxyphene from the U.S. market

Boston Scientific signs definitive agreement to acquire Sadra Medical

Acceleron presents ACE-041 interim results for advanced cancer at EORTC-NCI-AACR Symposium

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Heart Disease News and Research

Latest Heart Disease News and Research

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in